Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Head and Neck Neoplasms 4Glioblastoma 4Colorectal Neoplasms 4Stomach Neoplasms 3Glioma 3Esophageal Neoplasms 3Breast Neoplasms 3Brain Neoplasms 3Astrocytoma 3Recurrence 2Pancreatic Neoplasms 2Osteosarcoma 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Lung Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Hepatocellular 2Wilms Tumor 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Sarcoma 1Rhabdomyosarcoma 1Radiation Injuries 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Postoperative Complications 1

Interventions

Temozolomide 10Radiotherapy 5Radiation 4Magnetic Resonance Spectroscopy 4Ipilimumab 3pembrolizumab 2Specimen Handling 2Photons 2Nivolumab 2veliparib 1sargramostim 1peposertib 1montanide ISA 51 1liposomal doxorubicin 1cemiplimab 1balstilimab 1abexinostat 1X-Rays 1Vorinostat 1Utrogestan 1Surgical Procedures, Operative 1Sonication 1Progestins 1Progesterone 1Perfusion Magnetic Resonance Imaging 1Mycophenolic Acid 1Lomustine 1Irinotecan 1Drug Therapy 1Contrast Media 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gliosarcoma × Surgical Procedures, Operative × 90 days × Clear all
NCT07301268 2026-04-08

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Mayo Clinic

Phase 2 Recruiting
36 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡